CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell … – Science Daily
CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell …Science DailyIn PLAT-02, the CAR T cells are reprogrammed to recognize and target the CD19 protein that is expressed by most precursor B ac… Continue reading
